aXichem AB (publ), (aXichem), a developer of innovative natural analogue ingredients for the nutraceutical market, is pleased to announce that the company has signed a Letter of Intent (LOI) with Silver Fern Brand, a provider of premium health supplements. This collaboration aims to integrate aXivite into a broader product range, meeting the demand for science-backed health supplements.
“I see this LOI as a strategic step to broaden aXichem's global market presence and customer base. aXichem is committed to expanding aXivite's applications in sectors like weight management, sports nutrition, and gut health and we are looking forward to a fruitful partnership with Silver Fern Brand to bring shared success and value to customers and stakeholders. The initial focus of the collaboration is to develop a nutritional supplement for gut health, that utilizes aXivite's documented properties,” says Lucas Altepost, VP and Chief Sales and Marketing Officer at aXichem.
About Silver Fern Brand Silver Fern Brand is committed to health and wellness, with a focus on digestive health as a cornerstone for overall well-being. Silver Fern Brand collaborates with experts in microbiology and nutrition to create clean, science-backed, quality-tested and effective health products. The company is named after the New Zealand native Silver Fern, symbolizing strength and resilience.
About phenylcapsaicin and aXivite aXichem's proprietary molecule, phenylcapsaicin, combines the naturally occurring phenyl group with capsaicin, connected by a triple bond. The result is an innovative natural analog capsaicin with high purity, which in several studies has been shown to have the same health-promoting properties, as well as some unique benefits, as natural capsaicin. Phenylcapsaicin is approved under Novel Food in the EU and GRAS Food in the USA and is marketed for dietary supplements and functional foods under the brand name aXivite.
The information was submitted, through the care of the contact person below, for publication on
14 February 2024, at 9:00 CET.
